Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

KIDNEY CANCER

Variability in prognostic models for localized renal cell carcinoma

Nature Reviews Urology volume 19, pages 385–386 (2022)Cite this article

Subjects

Prognostic models incorporating clinical and pathological parameters might assist clinicians in counselling and surveillance of patients following surgical resection of renal cell carcinoma (RCC). Variability exists in the risk classification of individual patients in each model as well as the performance of each model in different RCC subtypes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2021. CA Cancer J. Clin. 71, 7–33 (2021).

    Article  Google Scholar 

  2. Teloken, P. E. et al. Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma. J. Urol. 182, 2132–2136 (2009).

    Article  Google Scholar 

  3. Nguyen, D. P. et al. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy. Urol. Oncol. 34, 259.e1–259.e8 (2016).

    Article  Google Scholar 

  4. Cheaib, J. G. et al. Stage-specific conditional survival in renal cell carcinoma after nephrectomy. Urol. Oncol. 38, 6.e1–6.e7 (2020).

    Article  Google Scholar 

  5. Rosiello, G. et al. Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma. Urol. Oncol. https://doi.org/10.1016/j.urolonc.2021.12.010 (2022).

    Article  PubMed  Google Scholar 

  6. Kriegmair, M. C. et al. Systematic review of the management of local kidney cancer relapse. Eur. Urol. Oncol. 1, 512–523 (2018).

    Article  Google Scholar 

  7. All, S., Garant, A. & Hannan, R. Stereotactic ablative radiation (SAbR) for oligometastatic RCC. Semin. Radiat. Oncol. 31, 227–234 (2021).

    Article  Google Scholar 

  8. Choueiri, T. K. et al. Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma. N. Engl. J. Med. 385, 683–694 (2021).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA

    Thomas Gerald & Vitaly Margulis

Authors
  1. Thomas Gerald
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vitaly Margulis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Gerald.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gerald, T., Margulis, V. Variability in prognostic models for localized renal cell carcinoma. Nat Rev Urol 19, 385–386 (2022). https://doi.org/10.1038/s41585-022-00590-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41585-022-00590-5

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer